Regional Dissemination Conference

Slides:



Advertisements
Similar presentations
2008 Johns Hopkins Bloomberg School of Public Health Setting Up a Smoking Cessation Clinic Sophia Chan PhD, MPH, RN, RSCN Department of Nursing Studies.
Advertisements

What is the evidence for time limiting addiction treatment?
Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Community-based Clinical Trials: Site Variation and Adoption of Innovation Dennis McCarty, PhD Allie Buti, MPH Lynn Kunkel, MS, CCRP Holly Fussell, PhD.
Welcome to CTN Mid-Atlantic Node/ Central East ATTC Webinar Series April 24, 2013 Vouchers and Fishbowls Clinical Trials Network Using Motivational Incentives.
Substance Use: Substance use comparisons included lifetime and past 30 day use (Figure 3) and lifetime use. For past 30 day use, more men reported heroin.
Comparative Effectiveness Research in the National Drug Abuse Treatment Clinical Trials Network (CTN) CDR Steven Sparenborg, Ph.D., Udi Ghitza, Ph.D.,
Contingency Management Motivational Incentives: Past, Present and Future Maxine Stitzer, Ph.D. Johns Hopkins University SOM NIDA/CTN Regional Dissemination.
10/15/2003 Copyright 2003 Aegis Medical Systems, Inc. All rights reserved. 1 Contingency Management in Community Treatment Programs Issues in Implementation.
Motivational Interviewing to Improve Treatment Engagement and Outcome* The effect of one session on retention Research findings from the NIDA Clinical.
Treatment of Methamphetamine Dependence: Does Treatment Work? Mary Lynn Brecht, Ph.D. Richard A. Rawson, Ph.D Semel Institute for Neuroscience and Human.
TREATING SPECIAL POPULATIONS. OVERVIEW Tobacco Treatment Smoking Outcomes Co-occurring Disorders Integration Tobacco Prevention.
Promoting Awareness of Motivational Incentives F O R P O L I C Y M A K E R S Successful Treatment Outcomes Using Motivational Incentives.
Addiction Health Services Research Conference Lexington, KY Louise Haynes, MSW Adoption of HIV Counseling and Testing Following Completion of Randomized.
MIEDAR, PAMI and BEYOND Maxine Stitzer, Ph.D. Johns Hopkins SOM APHA Symposium Denver, CO November 10, 2010.
What’s So Great About Incentives ? What’s So Great About Incentives ? Brought to you by the CTN Mid-Atlantic Node Christine Higgins Dissemination Specialist.
Conditional Cash Transfers and Contingency Management Strategies in Substance Users Mark Hull MD, MHSc, FRCPC Clinical Assistant Professor, University.
Low-Cost Contingency Management in Community Settings
Welcome to CTN Mid-Atlantic Node/CEATTC Webinar Series Clinical Trials Network Using Motivational Incentives in Behavioral Health Treatment.
Practical Application of Contingency Management Michael J. McCann, MA Matrix Institute on Addictions.
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
Attractive Addiction Treatment...? Can we make addiction treatment engaging?
Audrey J. Brooks, PhD University of Arizona CA-AZ node.
Promoting Awareness of Motivational Incentives F O R C L I N I C I A N S Successful Treatment Outcomes Using Motivational Incentives.
Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio.
Contingency Management in Problem Gambling Treatment Jeremiah Weinstock, Ph.D. University of Connecticut Health Center Farmington, CT USA.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Harold I Perl, PhD Center for the Clinical Trials Network National Institute on Drug Abuse NIATx Summit and SAAS National Conference Boston, MA July 13,
Results of the Vivitrol Pilot in Los Angeles County Presented by: Desiree A. Crevecoeur-MacPhail, Ph.D. Research Psychologist, UCLA ISAP.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
Contingency management: Using principles of reinforcement to improve drug abuse treatment Nancy Petry, Ph.D. University of Connecticut Health Center Farmington,
Increasing Attendance and Compliance With Incentives Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM Improving Care Conference Johns Hopkins Center for Behavior.
Specific Aims  Modify a previously used ACASI (audio computer assisted structured interview) assessment tool, the Sexual Behavior Inventory (SBI), for.
MIA: STEP Toolkit Overview. NIDA-SAMHSA Blending Initiative 2 What is an MI Assessment?  Use of client-centered MI style  MI strategies that can be.
EMPIRICALLY-SUPPORTED TREATMENTS FOR STIMULANT DEPENDENCE RICHARD A. RAWSON, Ph.D. UCLA INTEGRATED SUBSTANCE ABUSE PROGRAMS (ISAP) October 9, 2004.
Contingency Management Contingency management (CM) refers to the systematic application of basic principles delineated by workers in the field of the Experimental.
Are Incentives Effective in Improving Participation and Outcomes in Treatment for Substance-Abusing Offenders? Michael L. Prendergast, Ph.D. Elizabeth.
MOTIVATIONAL INCENTIVES IN THE CTN: RESULTS, CLINICAL IMPLICATIONS, AND DISSEMINATION CHRISTINE HIGGINS, DISSEMINATION SPECIALIST, CTN-MID-ATLANTIC NODE.
Elizabeth WellsDennis Daley School of Social WorkWestern Psychiatric Institute University of WashingtonUniversity of Pittsbu rgh Supported by Grants #
Criminal Justice Referral and Incentives in Outpatient Substance Abuse Treatment Anthony DeFulio 1, Paul Nuzzo 2, & Maxine Stitzer 1 1 – Johns Hopkins.
CCTN September 6 th, Recent Scientific Publications from the Clinical Trials Network David Liu, M.D. (CTN-0029) Harold Perl, Ph.D. (CTN-0015) Paul.
Michael Levy, Ph.D. VP of Clinical Services Northeast Behavioral Health.
Motivational Incentives: Utility in Health Care Settings Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM Christiana Care Health Systems Conference Addressing.
PAMI Promoting Awareness of Motivational Incentives: Focus on Founding Principles and an Implementation Checklist Donald A Calsyn, Ph.D. Pacific Northwest.
Raymond F. Anton, MD for The COMBINE Study Research Group
Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.
Abstinence Incentives for Methadone Maintained Stimulant Users: Outcomes for Those Testing Stimulant Positive vs Negative at Study Intake Maxine L. Stitzer.
Patient and Staff Satisfaction in Outpatient Substance Abuse Treatment Programs A. Kulaga 1, B. McClure 1, J. Rotrosen 1, P. Crits-Christoph 2, S. Ring-Kurtz.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Methamphetamine: User Characteristics and Treatment Response Alice Huber, Ph.D. Steven Shoptaw, Ph.D. Richard A. Rawson, Ph.D. Paul Brethen, M.A. Walter.
Abstinence Incentive Effects in Psychosocial Counseling Patients Testing Stimulant Positive vs Negative at Treatment Entry Maxine L. Stitzer Johns Hopkins.
California Addiction Training and Education Series Jeanne L. Obert, MFT, MSM Executive Director, Matrix Institute on Addictions Methamphetamine Behavioral.
Promoting Awareness of Motivational Incentives F O R C L I N I C I A N S Successful Treatment Outcomes Using Motivational Incentives.
Adoption of HIV Counseling and Testing Following Completion of Randomized Clinical Trial Louise Haynes 1, Beverly Holmes 2, Anna Amberg 2, Kathleen Brady.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
BEHAVIORAL FAMILY COUNSELING AND NALTREXONE FOR MALE OPIOID-DEPENDENT PATIENTS William Fals-Stewart, Ph.D. Research Institute on Addictions.
Practical Application of Contingency Management Michael J. McCann, MA Matrix Institute on Addictions.
What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
Trends in Access to Substance Abuse Treatment for Women and Men: Jeanne C. Marsh, PhD, Hee-Choon Shin, PhD, Dingcai Cao, PhD University of Chicago.
Methadone maintenance in Michigan: Five years of data using a contingency management approach Gary Rhodes, M.A., L.L.P. Golfo Tzilos, M.A. Mark Greenwald,
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Predictors of study retention in drug abuse treatment trials
2017 Epidemiological Report
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Contingency Management
Outline and Evaluate the Behavioural Approach to Addiction
Efforts to Reduce Meth Use and Sexual Risk
Vision Transformative collaboration that fosters resilient self-sustaining Recovery Communities. Mission To develop and sustain measurable solutions that.
The Judicial Branch’s Response to the Opioid Crisis
Presentation transcript:

Regional Dissemination Conference Contingency Management Motivational Incentives: Past, Present and Future Maxine Stitzer, Ph.D. Johns Hopkins University SOM NIDA/CTN Regional Dissemination Conference Baltimore, MD June 3, 2010

What you will hear today CM/Incentives Background Development and efficacy research Effectiveness testing National Drug Abuse Clinical Trials Network Implications for future Pathway for adoption by treatment providers

Drug User’s Dilemma Sober Living Continued Use Get a job Easy money Time with family Better health Easy money Hang with friends Get high Sober Living Continued Use

Motivational Incentives Can Counteract Ambivalence Make sober living a more attractive option through positive reinforcement of abstinence and other behavior change

People Respond to Consequences Behavior can be changed by consequences Rewards increase desired behavior Punishment and sanctions decrease undesired behavior

Contingency Management: Application in Drug Abuse Measurable target behavior Rewarding consequence

Application in Drug Abuse Treatment: Early Studies Behavioral targets: Counseling attendance Drug use during treatment On-time fee payment Reinforcing consequences: Money (or vouchers) Privileges (e.g. methadone take-home doses)

Incentive Effects on Benzodiazepine Use 3-month intervention with methadone maintained benzo users; incentive is take-home or money Percent benzo negative urines Before incentives 9% During incentives 53% After incentives 11% Stitzer et al., 1982

Voucher Reinforcement making cocaine abstinence a more attractive option Intensive counseling plus Points earned for cocaine negative urine results Escalating schedule with reset penalty Trade in points for goods $1000 available in first 3 months Steve Higgins

Voucher Incentives in Outpatient Drug-free Treatment Higgins et al. Am. J. Psychiatry, 1993 Cocaine negative urines

Voucher Incentives in Cocaine Abusing Methadone Patients Silverman et al., 1996 100 Control Vouchers 80 Percent Cocaine Negative 60 * * * * * * * * 40 20 1 2 3 4 5 2 4 6 8 10 12 Baseline Intervention Weeks

Voucher Reinforcement Elegantly incorporates behavioral principles designed to initiate & sustain abstinence Demonstrated efficacy in controlled trials BUT Sample sizes are small Costs were high ($1000 per client could be earned)

$1000??? You’ve got to be kidding!!!

Nancy Petry’s Fishbowl: Intermittent Reinforcement Schedule For cost reduction in community clinic settings

Fishbowl Method Incentive = draws from a bowl - Draws earned for each negative urine or BAC - Number of draws can escalate - Bonus draws can be given for consecutive weeks of abstinence

Half the slips are winners Win frequency inversely related to cost largest chance of winning a small $1 prize moderate chance of winning a large $20 prize small chance of winning a jumbo $100 prize

Retention: Alcoholics in Outpatient Psychosocial Treatment Petry et al., 2000

Percent positive for any illicit drug Petry et al., 2000

Efficacy of abstinence reinforcement demonstrated Drug-free and methadone treatment populations Voucher and prize draw methods

Generality of Abstinence Reinforcement Effects Across Abused Substances Cocaine (Higgins et al., 1994; Silverman et al., 1996, 2004; Petry & Martin, 2002) Alcohol (Petry et al., 2000) Opioids (Bickel et al., 1997; Silverman et al., 1996) Marijuana (Budney et al., 1991, 2000, 2006) Nicotine (Tobacco smoking) (Stitzer & Bigelow, 1984; Roll et al., 1996; Shoptaw et al., 2002)

National Drug Abuse Treatment Clinical Trials Network Bridging the gap between research and practice Clinicians Researchers

CTN Mission Conduct effectiveness research with community treatment partners Do interventions developed and studied in research clinics work when tested in the real world settings? If so, how can we make these new treatments part of usual care?

How do abstinence incentives fit into the clinical picture? Add-on to counseling as usual Special intervention to enhance motivation for sustained abstinence Focuses on the positive to recognize and celebrate success Allows counselors to work on life-style changes that can sustain abstinence beyond incentives

CTN MIEDAR Study Participants = 800 stimulant users (cocaine or methamphetamine) Conducted in: 6 methadone and 8 drug-free programs

Random Assignment • Usual care enhanced with abstinence incentives 3-month evaluation

Sample Collection Twice Weekly

Intermittent Reinforcement Schedule: Draws from the Abstinence Bowl Good Job Small Jumbo Good Job Large Small Small Large Small Good Job Good Job Good Job Good Job Good Job Good Job Small Good Job

Stimulant- and Alcohol-Free Test Results Draws Escalate with Stimulant- and Alcohol-Free Test Results Weeks Drug Free # Draws 1 2 4 5 3

Opiate and Marijuana Abstinence Bonus Draws for Opiate and Marijuana Abstinence # Draws 2 2 2 2 2 Weeks Drug Free

Half the chips are winners Examples of Prizes 42% 8% SMALL ($1-$5 items) LARGE ($20 items) JUMBO ($80-$100 items)

Total Earnings $400 in prizes could be earned on average If participant tested negative for all targeted drugs over 12 consecutive weeks

MIEDAR: Who participated and how did it turn out?

PATICIPANT DEMOGRAPHICS METH PSYCH (N=388) (N=415) FEMALE (%) 45 55 MINORITY (%) 49 58 AGE (mean yrs) 42 36 EDUC (mean yrs) 12 12 EMPLOYED (%) 32 35 PROB/PAROLE (%) 16 36 METH DOSE(mg) 86 --- TIME IN TX (mos) 9 1

METHADONE PROGRAM STUDY RESULTS

Study Retention in Methadone Treatment 100 80 Percentage Retained 60 Control Incentive 40 20 RH = 1.1 CI = 0.8,1.6 2 4 6 8 10 12

Percent Stimulant Negative Urines 1 A b s t i n e c I v U u a l C r 8 6 Percentage of stimulant negative urine samples 4 2 OR=1.91 (1.4-2.6) 1 3 5 7 9 1 1 1 3 1 5 1 7 1 9 2 1 2 3 S t u d y V i s i t

Individual Subject Performance 21% Incentive vs 8% control had prolonged abstinence outcome (19-24 Stimulant Negative Urines)

Outpatient Psychosocial Clinics: Contrasting Outcomes

Percent Stimulant Negative Urines

Incentives Improve Retention in Counseling Treatment 100 Control Incentive 80 60 50% Percentage Retained 40 35% 20 RH = 1.6 CI=1.2,2.0 2 4 6 8 10 12 Study Week

Psychosocial Site Differences: Raising Performance Abstinence incentives worked best in clinics with lower retention Control mean = 3.6 - 6.8 weeks Clinics where clients were usually retained for 8 weeks didn’t show improved retention with incentives

Individual Subject Performance 19% incentive vs 5% control had 12 weeks of stimulant negative samples

RESEARCH CONCLUSIONS Incentives can improve client outcomes on retention and drug use when implemented in community treatment programs

Dissemination/Adoption Clearly recognized as one evidence-based practice advocated by program funders and licensers 1/4 - 1/3 of clinics are currently using incentives- mostly to reinforce attendance (Roman et al., 2010) Information on what it is and how to do it increasingly available e.g. PAMI materials at www.nattc.org programs such as this one today

Should Kids Be Bribed To Do Well In School? TIME MAGAZINE April 8, 2010

Why Adopt Motivational Incentives. from Kellogg et al Why Adopt Motivational Incentives? from Kellogg et al., Something of Value, JSAT, 2005

Counselors Come to Understand Reinforcement “We came to see that we need to reward people where rewards in their lives were few and far between We use the rewards as a clinical tool – not as bribery, but for recognition The really profound rewards will come later” 49 49

Clients Like it “Clients are proud and are having fun Early in treatment, when their name is called out, they are feeling good that they are being acknowledged For once in their life, they are being rewarded for something” 50 50

Contributes to Positive Clinician-Client Interaction When patients publicly, and sometimes tearfully, acknowledged the counselor’s help in public, the staff felt a sense of gratitude “In the last two award ceremonies, clients said, ‘I want to thank the staff….’ That sounded real good – we felt appreciated” 51 51

Looking Into the Future Peace, Prosperity and… Prizes in every clinic!

Motivational Incentive Workshops

Incentive Approaches for Clinicians Christine Higgins Dissemination Specialist CTN Mid Atlantic Node

Incentive Contracting for Adolescents Ashli Sheidow, Ph.D. Associate Professor Psychiatry Family Services Research Ctr Medical Univ South Carolina

Incentive Implementation for Administrators Salon A Jim Beiting Executive Director Community Behavioral Health Hamilton, Ohio